GlucoTrack announces USD 11.5 million convertible notes offering

PUBT · 2d ago
GlucoTrack announces USD 11.5 million convertible notes offering
  • GlucoTrack announced definitive agreements for USD 11.5 million of convertible notes, including USD 4.5 million of new cash investment.
  • Transaction includes USD 4.5 million of existing notes rolled over, with aggregate principal reflecting a 22% original issue discount.
  • Convertible debt carries an initial conversion price of USD 3.12 per share.
  • Investors also receive warrants exercisable at USD 7.5 per share.
  • Dawson James Securities is sole placement agent.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GlucoTrack Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260911828722) on September 11, 2026, and is solely responsible for the information contained therein.